[Dynamics of the level of acylhydroperoxides and platelet aggregation in chronic ischemic heart disease and essential hypertension during treatment].
Platelet aggregation has been found to be increased in chronic coronary disease of any type, whereas the acylhydroperoxide level was only increased in anginal patients. Conventional therapy normalizes platelet aggregation in patients with angina or angina plus essential hypertension, yet it has no effect on acylhydroperoxides. In essential hypertension, platelet aggregation and acylhydroperoxides increase near the time of discharge.
D000328:Adult; D000368:Aged; D003327:Coronary Disease / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D008054:Lipid Peroxides / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation
D008054:Lipid Peroxides
Dinamika urovnia atsilgidroperekiseĭ i agregatsii trombotsitov u bol'nykh khronicheskoĭ ishemicheskoĭ bolezn'iu serdtsa i gipertonicheskoĭ bolezn'iu v protsesse lecheniia.